On 11 January 2019, orphan designation (EU/3/18/2125) was granted by the European Commission to Isabelle Ramirez, Germany, for benserazide hydrochloride for treatment of sickle cell disease.
|Disease / condition||
The treatment of sickle cell disease
|Date of decision||
|Orphan decision number||
Review of designation
Sponsor's contact details
For contact details of patients’ organisations whose activities are targeted at rare diseases, see: